Form4insider filings, from the source

SEC Form 4 · accession 0000902664-17-002486

PUMA BIOTECHNOLOGY, INC. · PBYI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Phillip Gross
10% Owner
Period of report
May 24, 2017
Accepted (ET)
May 26, 2017 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401667

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, par value $0.0001 ("Common Stock")F1,F2May 24, 2017S50,000$68.1291D5,636,668ISee footnote
Common StockF2May 24, 2017S39,115$69.00D5,597,553ISee footnote
Common StockF3,F2May 24, 2017S53,600$70.3077D5,543,953ISee footnote
Common StockF4,F2May 24, 2017S52,300$72.2167D5,491,653ISee footnote
Common StockF5,F2May 24, 2017S175,687$73.2885D5,315,966ISee footnote
Common StockF6,F2May 24, 2017S48,865$74.4872D5,267,101ISee footnote
Common StockF2May 24, 2017S116,133$75.00D5,150,968ISee footnote
Common StockF7,F2May 25, 2017S85,526$76.9061D5,065,442ISee footnote
Common StockF8,F2May 25, 2017S232,190$77.6149D4,833,252ISee footnote
Common StockF9,F2May 25, 2017S7,248$78.2452D4,826,004ISee footnote
Common StockF10,F2May 25, 2017S75,036$79.7026D4,750,968ISee footnote
Common StockF11,F2May 26, 2017S187,847$76.7156D4,563,121ISee footnote
Common StockF12,F2May 26, 2017S111,823$77.6639D4,451,298ISee footnote
Common StockF13,F2May 26, 2017S330$78.3545D4,450,968ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses